Who to call at Debiopharm, and when
Fundz watches for the moments Debiopharm starts buying, and tells you who to reach.
- An alert the day Debiopharm raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Debiopharm, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Debiopharm. With Fundz connected, it knows.
Watch Fundz in
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2
Contract Type
partnership
Description
Debiopharm and WhiteLab Genomics have announced a strategic partnership to advance drug target and design in the field of oncology.
Quick answer
Debiopharm and WhiteLab Genomics Announce Strategic Partnership in Oncology (September 16, 2024). Debiopharm is based in Lausanne, Vaud, Switzerland.
- What agreement did Debiopharm announce on September 16, 2024?
- Debiopharm and WhiteLab Genomics have announced a strategic partnership to advance drug target and design in the field of oncology.
- What does Debiopharm do?
- Debiopharm is a privately-owned, Swiss-based, biopharmaceutical company aiming to establish tomorrow’s standard-of-care to cure cancer and infectious diseases.
- Where is Debiopharm based?
- Debiopharm is based in Lausanne, Vaud, Switzerland.
Source: Fundz verified event record.
Related People
Agreement Insights
What this usually meansStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Debiopharm signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.